Evaluation of the Role of Plasma Procalcitonin in Prediction of Intra-amniotic Infection in Prete… (NCT02104791) | Clinical Trial Compass
UnknownNot Applicable
Evaluation of the Role of Plasma Procalcitonin in Prediction of Intra-amniotic Infection in Preterm Premature Rupture of Membrane
Egypt100 participantsStarted 2014-05
Plain-language summary
It is hypothesized that the procalcitonin has a role to play in prediction of intra-amniotic subclinical infection.
Who can participate
Age range20 Years – 40 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Patients are with singleton pregnancies. Rupture of membranes will be diagnosed by history, sterile speculum examination to confirm fluid leakage from the cervical canal and ultrasound to confirm oligohydraminos.
Subclinical infection will be detected with laboratory indices (WBC count of ≥15, 000 c/mm3, CRP of ≥1 mg/dL) without any clinical symptoms and signs of infection as urinary tract infection in group 1 patients.
Women with multiple pregnancies. Clinical signs of infection as (fever,abdominal tendernes). Cervical dilatations of 2 cm or more. Maternal disease like diabetes or fetal complications like intra-uterine fetal death.
Inclusion Criteria:
\-
Exclusion Criteria:
\-
What they're measuring
1
The correlation between procalcitonin level in PPROM and C-reactive protein level in neonates.